Alvotech reaches settlements with J&J for Stelara biosimilar launch

Alvotech SA

15/02/2024 11:39

Feb 15 (Reuters) - Alvotech  ALVO.O  said on Thursday it
has reached settlement agreements with Johnson & Johnson  JNJ.N 
for launching the biosimilar of the pharmaceutical giant's
blockbuster psoriasis drug Stelara in Japan, Canada and the
European Economic Area.

 (Reporting by Leroy Leo in Bengaluru; Editing by Shounak
Dasgupta)
 ((Leroy.Dsouza@thomsonreuters.com; https://twitter.com/LeroyLeo7))